PHAM QUANG X (CEO and Chairman) sold 0.6% of their position (1.17K shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/27/2026ACC: 0001213900-26-061167
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
-1.17K
Net shares
Net seller
$6.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.17K
Price / share
$5.69
Trade value
$6.63K
% of position
0.6%
5/22/2026
196.09K→194.92K
Total
Net shares
−1.17K
Net value
-$6.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | S · Sale | −1.17K | $5.69 | $6.63K | 0.6% | 196.09K | 194.92K |
| Total | −1.17K | -$6.63K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported